imatinib mesylate has been researched along with Hematoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, HK; Kim, AY; Kim, HJ; Kim, JS; Lee, JS; Park, SH | 1 |
| Abbass, K; Agrawal, S; Akram, S; Markert, R; Poland, E | 1 |
2 other study(ies) available for imatinib mesylate and Hematoma
| Article | Year |
|---|---|
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Disease Progression; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hematoma; Hemoperitoneum; Humans; Imatinib Mesylate; Indoles; Intestine, Small; Male; Middle Aged; Necrosis; Peritonitis; Pyrroles; Rupture, Spontaneous; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Young Adult | 2017 |
Gastrointestinal Stromal Tumor Masquerading as a Spontaneous Rectal Hematoma.
Topics: Aged; Antineoplastic Agents; Colonoscopy; Diagnosis, Differential; Endosonography; Gastrointestinal Stromal Tumors; Hematoma; Humans; Imatinib Mesylate; Male; Prognosis; Rectal Neoplasms; Tomography, X-Ray Computed | 2012 |